Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study
出版年份 2019 全文链接
标题
Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study
作者
关键词
-
出版物
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-12-20
DOI
10.1111/jdv.16159
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patients
- (2019) Vasiliki Nikolaou et al. SUPPORTIVE CARE IN CANCER
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events
- (2019) Heike C. Hawerkamp et al. ALLERGY
- Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients
- (2018) Gregory S. Phillips et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Kinase-targeted cancer therapies: progress, challenges and future directions
- (2018) Khushwant S. Bhullar et al. Molecular Cancer
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institutional, retrospective analysis with stratification of reactions by toxicity and implications for management
- (2018) Emily Coleman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Outpatient dermatology consultation impacts the diagnosis and management of pediatric oncology patients: A retrospective study
- (2017) Hannah Song et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings
- (2017) V. Sibaud et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies
- (2016) Vincent Sibaud et al. CURRENT OPINION IN ONCOLOGY
- Association of Dermatology Consultation With Accuracy of Cutaneous Disorder Diagnoses in Hospitalized Patients
- (2016) Daniela Kroshinsky et al. JAMA Dermatology
- Xerosis and pruritus as major EGFRI-associated adverse events
- (2015) Julia M. K. Clabbers et al. SUPPORTIVE CARE IN CANCER
- Experience of a year of adult hospital dermatology consultations
- (2014) Eoin R. Storan et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- The Impact of Dermatology Consultation on Diagnostic Accuracy and Antibiotic Use Among Patients With Suspected Cellulitis Seen at Outpatient Internal Medicine Offices
- (2014) Ryan Y. Arakaki et al. JAMA Dermatology
- Impact of Dermatologic Adverse Events on Quality of Life in 283 Cancer Patients: A Questionnaire Study in a Dermatology Referral Clinic
- (2013) Alyx C. Rosen et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Life-threatening dermatologic adverse events in oncology
- (2013) Alyx C. Rosen et al. ANTI-CANCER DRUGS
- Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group
- (2013) Rebecca K. S. Wong et al. SUPPORTIVE CARE IN CANCER
- Rash with the multitargeted kinase inhibitors nilotinib and dasatinib: meta-analysis and clinical characterization
- (2012) Aaron M. Drucker et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0
- (2012) Alice P. Chen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study
- (2012) Emily Y. Chu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib
- (2011) IRIS AMITAY-LAISH et al. Dermatologic Therapy
- The emergence of supportive oncodermatology: The study of dermatologic adverse events to cancer therapies
- (2011) Yevgeniy Balagula et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review
- (2011) C. B. Boers-Doets et al. ONCOLOGIST
- Pediatric Dermatology Consultations: A Retrospective Analysis of Inpatient Consultations Referred to the Dermatology Service
- (2011) YERAY PEÑATE et al. PEDIATRIC DERMATOLOGY
- Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
- (2011) Mario E. Lacouture et al. SUPPORTIVE CARE IN CANCER
- Dermatology inpatient consultations: A retrospective study
- (2010) Jacob Bauer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of Hand-Foot Skin Reaction with the Multitargeted Kinase Inhibitor Sunitinib in Patients with Renal Cell and Non–Renal Cell Carcinoma: A Meta-analysis
- (2009) David Chu et al. Clinical Genitourinary Cancer
- Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib
- (2008) S. E. Rosenbaum et al. SUPPORTIVE CARE IN CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search